Clinica Medica Virgen De Guadalupe #2 - Medicare Primary Care in Huntington Park, CA

Clinica Medica Virgen De Guadalupe #2 is a medicare enrolled primary clinic (General Practice) in Huntington Park, California. The current practice location for Clinica Medica Virgen De Guadalupe #2 is 6831 Seville Ave, Huntington Park, California. For appointments, you can reach them via phone at (323) 581-8234. The mailing address for Clinica Medica Virgen De Guadalupe #2 is 6831 Seville Ave, Huntington Park, California and phone number is (323) 581-8234.

Clinica Medica Virgen De Guadalupe #2 is licensed to practice in California (license number A048644). The clinic also participates in the medicare program and its NPI number is 1033240650. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (323) 581-8234.

Contact Information

Clinica Medica Virgen De Guadalupe #2
6831 Seville Ave
Huntington Park
CA 90255-4805
(323) 581-8234
(323) 581-0393

Primary Care Clinic Profile

Full NameClinica Medica Virgen De Guadalupe #2
SpecialityGeneral Practice
Location6831 Seville Ave, Huntington Park, California
Authorized Official Name and PositionCorina Ayers (ADMINISTRATOR)
Authorized Official Contact3235818234
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Clinica Medica Virgen De Guadalupe #2
6831 Seville Ave
Huntington Park
CA 90255-4805

Ph: (323) 581-8234
Clinica Medica Virgen De Guadalupe #2
6831 Seville Ave
Huntington Park
CA 90255-4805

Ph: (323) 581-8234

NPI Details:

NPI Number1033240650
Provider Enumeration Date03/07/2007
Last Update Date08/22/2020

Medicare PECOS Information:

Medicare PECOS PAC ID7810955655
Medicare Enrollment IDO20041228000291

News Archive

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

Genetically engineered mexican lime contains anthocyanins that has several potential benefits

Anthocyanins, pigments that give plants their red, blue, or purple hues, are not typically produced in citrus fruits grown under tropical or subtropical conditions. Now, scientists have genetically engineered a lime that contains anthocyanins, which they say has several potential benefits.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Clinica Medica Virgen De Guadalupe #2 such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033240650NPI-NPPES
GR0067941MedicaidCA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine A61918 (California)Primary
208D00000XGeneral Practice A048644 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Clinica Medica Virgen De Guadalupe #2 acts as a billing entity for following providers:
Provider NameHumberto Herrera
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1174543326
PECOS PAC ID: 1254480833
Enrollment ID: I20090602000067

News Archive

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

Genetically engineered mexican lime contains anthocyanins that has several potential benefits

Anthocyanins, pigments that give plants their red, blue, or purple hues, are not typically produced in citrus fruits grown under tropical or subtropical conditions. Now, scientists have genetically engineered a lime that contains anthocyanins, which they say has several potential benefits.

Read more Medical News

› Verified 9 days ago

Provider NameVioleta A Galdamez
Provider TypePractitioner - Pediatric Medicine
Provider IdentifiersNPI Number: 1316078165
PECOS PAC ID: 2961460605
Enrollment ID: I20120607000118

News Archive

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

Genetically engineered mexican lime contains anthocyanins that has several potential benefits

Anthocyanins, pigments that give plants their red, blue, or purple hues, are not typically produced in citrus fruits grown under tropical or subtropical conditions. Now, scientists have genetically engineered a lime that contains anthocyanins, which they say has several potential benefits.

Read more Medical News

› Verified 9 days ago

Provider NameLuis A Galdamez
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1679604417
PECOS PAC ID: 7416915152
Enrollment ID: I20120703000651

News Archive

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

Genetically engineered mexican lime contains anthocyanins that has several potential benefits

Anthocyanins, pigments that give plants their red, blue, or purple hues, are not typically produced in citrus fruits grown under tropical or subtropical conditions. Now, scientists have genetically engineered a lime that contains anthocyanins, which they say has several potential benefits.

Read more Medical News

› Verified 9 days ago

Provider NameMonica Irene Benitez
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861151045
PECOS PAC ID: 0345615811
Enrollment ID: I20230414001184

News Archive

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

Genetically engineered mexican lime contains anthocyanins that has several potential benefits

Anthocyanins, pigments that give plants their red, blue, or purple hues, are not typically produced in citrus fruits grown under tropical or subtropical conditions. Now, scientists have genetically engineered a lime that contains anthocyanins, which they say has several potential benefits.

Read more Medical News

› Verified 9 days ago

News Archive

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

Genetically engineered mexican lime contains anthocyanins that has several potential benefits

Anthocyanins, pigments that give plants their red, blue, or purple hues, are not typically produced in citrus fruits grown under tropical or subtropical conditions. Now, scientists have genetically engineered a lime that contains anthocyanins, which they say has several potential benefits.

Read more News

› Verified 9 days ago


General Practice in Huntington Park, CA

Optimal Care Medical Group
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2675 E Slauson Ave, Huntington Park, CA 90255
Phone: 323-749-6777    Fax: 323-835-6035
Los Angeles Clinica Medica General Medical Center, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7400 Pacific Blvd Ste Ab, Huntington Park, CA 90255
Phone: 323-583-8383    Fax: 323-583-8399
The Oasis Medical Clinic Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2635 Walnut St, Huntington Park, CA 90255
Phone: 323-200-4525    
Union Medical Clinic Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5421 Pacific Blvd, Huntington Park, CA 90255
Phone: 323-587-9141    Fax: 323-587-6074
John Paul Ii Medical Clinic Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6529 Seville Ave, Huntington Park, CA 90255
Phone: 323-582-5770    Fax: 323-582-1103
Paul M Baylon Md Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3118 E Florence Ave, Huntington Park, CA 90255
Phone: 323-587-1616    Fax: 323-587-1767

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.